Search research articles
Contact Us
Filters
Showing results (11-20 of 416) with videos related to
Page
of 42
Sort By:
Trends in Pharmacological Sciences
|
March 3, 2019
Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors
Branden J Stansley, P Jeffrey Conn
Neurodegenerative Disease Management
|
March 26, 2013
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease
Jonathan W Dickerson, P Jeffrey Conn
Annual Review of Medicine
|
October 13, 2025
Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia
P Jeffrey Conn, Steven M Paul
Pharmacology, Biochemistry, and Behavior
|
October 12, 2002
Metabotropic glutamate receptors
D D Schoepp, P Jeffrey Conn
Current Opinion in Pharmacology
|
February 28, 2018
The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia
Branden J Stansley, P Jeffrey Conn
Current Drug Targets. CNS and Neurological Disorders
|
May 29, 2003
Direct and indirect modulation of the N-methyl D-aspartate receptor
M J Marino, P Jeffrey Conn
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2006
mGluR7's lucky number
P Jeffrey Conn, Colleen M Niswender
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 25, 2008
Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings
P Jeffrey Conn, Bryan L Roth
Annual Review of Pharmacology and Toxicology
|
January 9, 2010
Metabotropic glutamate receptors: physiology, pharmacology, and disease
Colleen M Niswender, P Jeffrey Conn
The International Journal of Neuropsychopharmacology
|
December 10, 2015
Neurobiological Insights from mGlu Receptor Allosteric Modulation
Daniel E O'Brien, P Jeffrey Conn
Page
of 42
Search research articles
Search
Showing results (11-20 of 416) with videos related to
Sort By:
Page
of 42
Trends in Pharmacological Sciences
|
March 3, 2019
Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors
Branden J Stansley, P Jeffrey Conn
Neurodegenerative Disease Management
|
March 26, 2013
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease
Jonathan W Dickerson, P Jeffrey Conn
Annual Review of Medicine
|
October 13, 2025
Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia
P Jeffrey Conn, Steven M Paul
Pharmacology, Biochemistry, and Behavior
|
October 12, 2002
Metabotropic glutamate receptors
D D Schoepp, P Jeffrey Conn
Current Opinion in Pharmacology
|
February 28, 2018
The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia
Branden J Stansley, P Jeffrey Conn
Current Drug Targets. CNS and Neurological Disorders
|
May 29, 2003
Direct and indirect modulation of the N-methyl D-aspartate receptor
M J Marino, P Jeffrey Conn
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2006
mGluR7's lucky number
P Jeffrey Conn, Colleen M Niswender
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 25, 2008
Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings
P Jeffrey Conn, Bryan L Roth
Annual Review of Pharmacology and Toxicology
|
January 9, 2010
Metabotropic glutamate receptors: physiology, pharmacology, and disease
Colleen M Niswender, P Jeffrey Conn
The International Journal of Neuropsychopharmacology
|
December 10, 2015
Neurobiological Insights from mGlu Receptor Allosteric Modulation
Daniel E O'Brien, P Jeffrey Conn
Page
of 42